1. Home
  2. TTI vs SPTX Comparison

TTI vs SPTX Comparison

Compare TTI & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TTI

Tetra Technologies Inc.

HOLD

Current Price

$8.45

Market Cap

1.1B

Sector

Energy

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$22.34

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TTI
SPTX
Founded
1981
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
TTI
SPTX
Price
$8.45
$22.34
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$10.40
N/A
AVG Volume (30 Days)
1.6M
92.7K
Earning Date
04-29-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
N/A
N/A
Revenue This Year
$4.70
N/A
Revenue Next Year
$11.35
N/A
P/E Ratio
$66.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.82
$17.59
52 Week High
$12.54
$22.98

Technical Indicators

Market Signals
Indicator
TTI
SPTX
Relative Strength Index (RSI) 46.73 61.50
Support Level $7.71 $18.72
Resistance Level $9.07 $22.42
Average True Range (ATR) 0.57 1.41
MACD 0.04 0.03
Stochastic Oscillator 64.37 86.46

Price Performance

Historical Comparison
TTI
SPTX

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments, namely Completion Fluids & Products and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Segment provides onshore oil and gas operators with comprehensive water management services. The majority of revenue is from the Completion Fluids & Products segment.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: